← Leaderboards
Richard Holubkov
Johns Hopkins University
$11,946,832
Attributed
$31,987,354
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.9M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,987,354 · 4
By mechanism
U01$31,987,354 · 4
Top collaborators
- John Kestle9 shared
- Abhaya V Kulkarni9 shared
- David Delmar Limbrick9 shared
- Mark Gregory Luciano7 shared
- Colin Kerst Grissom5 shared
- Rajendu Srivastava5 shared
- Michael J Bell2 shared
- Chani Traube2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Henry R Halperin$35,491,139
- Mark Gregory Luciano$10,508,934
- Jason Edward Farley$4,770,623
- Gregory B Diette$8,022,684
- Denise Evans$1,218,502
Others in their field
Other Emerging Leaders on “Cognitive”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Carina Remgsamai-Nhe · Fisher Bioservices, Inc.$46,307,940
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$22,096,142
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
Research focus
CognitiveAffectOperative Surgical ProceduresVentricularShunt DevicePrimary OutcomeCerebrospinal Fluid Shunts ProcedureSurveysImageHydrocephalusRandomizedPerformanceLength Of StayLifeEffectivenessSiteGuidelinesProspectivePersonsClinical EffectivenessProceduresChildhoodChildAge Years
Grant awards (23)
Optimizing Pain Treatment In Children On Mechanical ventilation (OPTICOM)$3,444,892
U01 · FY2025 · HD
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$2,237,103
U01 · FY2025 · NS
Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation$993,929
U01 · FY2025 · HL
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$955,706
U01 · FY2025 · NS
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$52,775
U01 · FY2025 · NS
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$22,440
U01 · FY2025 · NS
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$21,660
U01 · FY2025 · NS
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$15,612
U01 · FY2025 · NS
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$8,605
U01 · FY2025 · NS
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$1,771
U01 · FY2025 · NS
Optimizing Pain Treatment In Children On Mechanical ventilation (OPTICOM)$3,421,461
U01 · FY2024 · HD
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$3,266,140
U01 · FY2024 · NS
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$1,179,880
U01 · FY2024 · NS
Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation$987,124
U01 · FY2024 · HL
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$1,544,375
U01 · FY2023 · NS
Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation$1,014,255
U01 · FY2023 · HL
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$3,378,298
U01 · FY2022 · NS
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$1,492,187
U01 · FY2022 · NS
Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation$1,029,882
U01 · FY2022 · HL
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial$3,055,371
U01 · FY2021 · NS
Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation$619,678
U01 · FY2021 · HL
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$1,497,695
U01 · FY2020 · NS
Endoscopic versus Shunt Treatment of Hydrocephalus in Infants$1,746,515
U01 · FY2019 · NS